Published in Proc Natl Acad Sci U S A on October 07, 2002
Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev (2006) 5.08
Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) (2010) 2.99
Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol (2014) 2.73
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev (2012) 2.31
Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther (2009) 2.10
The Concise Guide to PHARMACOLOGY 2013/14: transporters. Br J Pharmacol (2013) 2.07
Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol (2010) 1.99
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes Dev (2010) 1.95
Structural biology of copper trafficking. Chem Rev (2009) 1.89
Inhibition of transcription by platinum antitumor compounds. Metallomics (2009) 1.88
Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids (2010) 1.82
Three-dimensional structure of the human copper transporter hCTR1. Proc Natl Acad Sci U S A (2009) 1.79
Systems biology of cisplatin resistance: past, present and future. Cell Death Dis (2014) 1.74
New roles for copper metabolism in cell proliferation, signaling, and disease. J Biol Chem (2008) 1.70
Projection structure of the human copper transporter CTR1 at 6-A resolution reveals a compact trimer with a novel channel-like architecture. Proc Natl Acad Sci U S A (2006) 1.66
Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther (2003) 1.61
The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. Am J Physiol Renal Physiol (2009) 1.56
The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs. Mol Pharmacol (2008) 1.56
New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. Proc Natl Acad Sci U S A (2003) 1.51
Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med Chem (2009) 1.49
EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer. PLoS One (2015) 1.46
Eukaryotic CTR copper uptake transporters require two faces of the third transmembrane domain for helix packing, oligomerization, and function. J Biol Chem (2004) 1.44
Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury. Sci Transl Med (2016) 1.40
Copper in the brain and Alzheimer's disease. J Biol Inorg Chem (2009) 1.40
Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken) (2012) 1.38
Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. Clin Cancer Res (2009) 1.37
Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell (2010) 1.35
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy. Met Based Drugs (2010) 1.25
Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1. Clin Cancer Res (2009) 1.22
Bio-metals imaging and speciation in cells using proton and synchrotron radiation X-ray microspectroscopy. J R Soc Interface (2009) 1.22
Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin. Mol Pharmacol (2009) 1.19
Pathophysiology of cisplatin-induced acute kidney injury. Biomed Res Int (2014) 1.18
Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci (2010) 1.17
Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells. Mol Pharmacol (2008) 1.16
Effects of the loss of Atox1 on the cellular pharmacology of cisplatin. J Inorg Biochem (2008) 1.16
Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11. Clin Cancer Res (2014) 1.16
Monofunctional and higher-valent platinum anticancer agents. Inorg Chem (2013) 1.13
Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol (2010) 1.12
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines. Br J Cancer (2003) 1.12
Nanocarriers for delivery of platinum anticancer drugs. Adv Drug Deliv Rev (2013) 1.11
Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1. Mol Pharmacol (2008) 1.09
Specificity protein 1 (sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression. Mol Pharmacol (2011) 1.07
Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci U S A (2013) 1.06
Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells. Mol Pharmacol (2010) 1.06
Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy. Cancer Res (2012) 1.05
The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin. Biochem J (2009) 1.05
Molecular and functional analyses of COPT/Ctr-type copper transporter-like gene family in rice. BMC Plant Biol (2011) 1.04
Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. J Ovarian Res (2011) 1.04
Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci U S A (2004) 1.03
A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells. Mol Pharmacol (2013) 1.03
Mechanistic basis for overcoming platinum resistance using copper chelating agents. Mol Cancer Ther (2012) 1.01
Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells. J Anal At Spectrom (2009) 1.01
Regulation of Cisplatin cytotoxicity by cu influx transporters. Met Based Drugs (2011) 1.00
Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients. PLoS One (2012) 0.99
Pharmacogenomics of platinum-based chemotherapy in NSCLC. Expert Opin Drug Metab Toxicol (2009) 0.97
Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin. Hear Res (2012) 0.96
Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain. Proc Natl Acad Sci U S A (2013) 0.96
Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue. Mol Cancer Ther (2010) 0.96
Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity. Int J Nanomedicine (2013) 0.95
An all-atom model of the structure of human copper transporter 1. Cell Biochem Biophys (2012) 0.95
Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells. Oncotarget (2014) 0.94
Platinum resistance in breast and ovarian cancer cell lines. J Exp Clin Cancer Res (2011) 0.94
Methionine motifs of copper transport proteins provide general and flexible thioether-only binding sites for Cu(I) and Ag(I). J Biol Inorg Chem (2010) 0.94
Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer. Br J Cancer (2015) 0.94
Platinum-induced neurotoxicity and preventive strategies: past, present, and future. Oncologist (2015) 0.93
Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil. Br J Cancer (2007) 0.93
Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1. J Biol Inorg Chem (2009) 0.92
Posttranslational regulation of copper transporters. J Biol Inorg Chem (2009) 0.92
Functional mechanotransduction is required for cisplatin-induced hair cell death in the zebrafish lateral line. J Neurosci (2013) 0.92
Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function. Am J Physiol Renal Physiol (2013) 0.91
Cisplatin ototoxicity in rat cochlear organotypic cultures. Hear Res (2011) 0.90
Contribution of tumoral and host solute carriers to clinical drug response. Drug Resist Updat (2012) 0.90
Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast. BMC Biol (2011) 0.90
The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin. Biochem Pharmacol (2010) 0.89
Molecular genetics of testicular germ cell tumors. Am J Cancer Res (2012) 0.89
Vitamin B6 metabolism influences the intracellular accumulation of cisplatin. Cell Cycle (2012) 0.89
Interaction of cisplatin and analogues with a Met-rich protein site. J Biol Inorg Chem (2008) 0.89
Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin. Metallomics (2014) 0.88
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer. Lung Cancer (2014) 0.87
Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs. Eukaryot Cell (2004) 0.87
SLC31 (CTR) family of copper transporters in health and disease. Mol Aspects Med (2013) 0.86
Tryptophan scanning analysis of the membrane domain of CTR-copper transporters. J Membr Biol (2010) 0.86
Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics. Mol Cancer Ther (2013) 0.86
Isolation and characterization of Saccharomyces cerevisiae mutants with enhanced resistance to the anticancer drug bleomycin. Curr Genet (2004) 0.85
Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice. Am J Pathol (2014) 0.85
Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines. Mol Cell Proteomics (2014) 0.85
Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells. Proc Natl Acad Sci U S A (2008) 0.85
Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy. Expert Opin Ther Targets (2015) 0.85
Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer. Genomics Proteomics Bioinformatics (2014) 0.85
DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells. PLoS One (2013) 0.85
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies. Invest New Drugs (2013) 0.84
Role of copper transporters in resistance to platinating agents. Cancer Chemother Pharmacol (2008) 0.84
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models. J Ovarian Res (2013) 0.84
Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy? Front Genet (2014) 0.83
Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures. J Ovarian Res (2012) 0.83
Molecular mechanisms of cisplatin resistance in cervical cancer. Drug Des Devel Ther (2016) 0.83
Gender difference in Cisplatin-induced nephrotoxicity in a rat model. Nephrourol Mon (2015) 0.82
Role of solute carriers in response to anticancer drugs. Mol Cell Ther (2014) 0.81
On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy. Bioinorg Chem Appl (2012) 0.81
Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner. Oncotarget (2014) 0.81
Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast (1998) 48.29
Large-scale analysis of gene expression, protein localization, and gene disruption in Saccharomyces cerevisiae. Genes Dev (1994) 6.12
Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell (1994) 3.88
Drugs five years later. Cisplatin. Ann Intern Med (1984) 3.69
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry (1985) 3.67
The Saccharomyces cerevisiae copper transport protein (Ctr1p). Biochemical characterization, regulation by copper, and physiologic role in copper uptake. J Biol Chem (1994) 2.57
Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci (1995) 2.36
Biochemical characterization of the human copper transporter Ctr1. J Biol Chem (2001) 2.28
Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc Natl Acad Sci U S A (2001) 2.19
MAC1, a nuclear regulatory protein related to Cu-dependent transcription factors is involved in Cu/Fe utilization and stress resistance in yeast. EMBO J (1993) 2.13
Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer (1993) 2.10
hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci U S A (1997) 2.04
Copper-dependent degradation of the Saccharomyces cerevisiae plasma membrane copper transporter Ctr1p in the apparent absence of endocytosis. EMBO J (1996) 1.93
Molecular characterization of a putative Arabidopsis thaliana copper transporter and its yeast homologue. J Biol Chem (1995) 1.86
A widespread transposable element masks expression of a yeast copper transport gene. Genes Dev (1996) 1.79
Copper-specific transcriptional repression of yeast genes encoding critical components in the copper transport pathway. J Biol Chem (1997) 1.76
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res (2000) 1.70
Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutant. Gene (2000) 1.64
Metalloregulation of FRE1 and FRE2 homologs in Saccharomyces cerevisiae. J Biol Chem (1998) 1.62
Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science (1993) 1.54
Clinical perspectives on platinum resistance. Drugs (2000) 1.52
Delivering copper inside yeast and human cells. Science (1997) 1.50
A series of protein phosphatase gene disruptants in Saccharomyces cerevisiae. Yeast (1999) 1.48
Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli. J Bacteriol (1973) 1.45
Homeostatic regulation of copper uptake in yeast via direct binding of MAC1 protein to upstream regulatory sequences of FRE1 and CTR1. J Biol Chem (1997) 1.45
Nucleotide-excision repair of DNA in cell-free extracts of the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1993) 1.44
Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II). Nucleic Acids Res (1985) 1.31
Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus. Mutat Res (1978) 1.21
Two nuclear proteins, Cin5 and Ydr259c, confer resistance to cisplatin in Saccharomyces cerevisiae. Mol Pharmacol (2001) 1.15
The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutat Res (1996) 1.11
The Fe(II) permease Fet4p functions as a low affinity copper transporter and supports normal copper trafficking in Saccharomyces cerevisiae. Biochem J (2000) 1.08
Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2). FEBS Lett (1999) 1.03
SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line. Cancer Res (2001) 1.02
A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatin. Biochem Biophys Res Commun (2000) 1.00
Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance. Biochem Biophys Res Commun (1995) 0.96
Loss of DNA mismatch repair due to knockout of MSH2 or PMS2 results in resistance to cisplatin and carboplatin. Int J Oncol (1997) 0.87
Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A (2003) 5.77
Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol (2008) 4.03
Genome-wide analysis of the biology of stress responses through heat shock transcription factor. Mol Cell Biol (2004) 3.61
Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation. Cell (2005) 3.05
Polo-like kinase Cdc5 promotes chiasmata formation and cosegregation of sister centromeres at meiosis I. Nat Cell Biol (2003) 2.94
Unique and redundant roles for HOG MAPK pathway components as revealed by whole-genome expression analysis. Mol Biol Cell (2003) 2.92
Control of landmark events in meiosis by the CDK Cdc28 and the meiosis-specific kinase Ime2. Genes Dev (2003) 2.79
Molecular mechanisms of copper uptake and distribution. Curr Opin Chem Biol (2002) 2.74
A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem (2009) 2.66
Yeast go the whole HOG for the hyperosmotic response. Trends Genet (2002) 2.45
Biochemical characterization of the human copper transporter Ctr1. J Biol Chem (2001) 2.28
Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev (2003) 2.27
Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake. J Biol Chem (2002) 2.24
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci U S A (2003) 2.03
Cardiac copper deficiency activates a systemic signaling mechanism that communicates with the copper acquisition and storage organs. Cell Metab (2010) 1.98
Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J Biol Chem (2002) 1.91
Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. J Biol Chem (2002) 1.89
Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. Cell Metab (2006) 1.84
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics (2003) 1.79
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat Rev Drug Discov (2011) 1.71
New roles for copper metabolism in cell proliferation, signaling, and disease. J Biol Chem (2008) 1.70
Anatomy and dynamics of DNA replication fork movement in yeast telomeric regions. Mol Cell Biol (2004) 1.69
Copper in microbial pathogenesis: meddling with the metal. Cell Host Microbe (2012) 1.69
Identification of a copper transporter family in Arabidopsis thaliana. Plant Mol Biol (2003) 1.64
The Khd1 protein, which has three KH RNA-binding motifs, is required for proper localization of ASH1 mRNA in yeast. EMBO J (2002) 1.62
A third osmosensing branch in Saccharomyces cerevisiae requires the Msb2 protein and functions in parallel with the Sho1 branch. Mol Cell Biol (2002) 1.58
Cooperation of two mRNA-binding proteins drives metabolic adaptation to iron deficiency. Cell Metab (2008) 1.57
Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics (2002) 1.57
Genomic dissection of the cell-type-specification circuit in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2004) 1.52
Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter. J Biol Chem (2004) 1.50
Activation of the Saccharomyces cerevisiae heat shock transcription factor under glucose starvation conditions by Snf1 protein kinase. J Biol Chem (2003) 1.49
Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease. PLoS Biol (2010) 1.47
Metal-responsive transcription factor (MTF-1) handles both extremes, copper load and copper starvation, by activating different genes. Genes Dev (2005) 1.46
Inhibition of DNA binding by differential sumoylation of heat shock factors. Mol Cell Biol (2006) 1.45
Cryptococcus neoformans copper detoxification machinery is critical for fungal virulence. Cell Host Microbe (2013) 1.45
Mobilization of intracellular copper stores by the ctr2 vacuolar copper transporter. J Biol Chem (2004) 1.45
Copper: an essential metal in biology. Curr Biol (2011) 1.45
The Arabidopsis heavy metal P-type ATPase HMA5 interacts with metallochaperones and functions in copper detoxification of roots. Plant J (2006) 1.43
The Arabidopsis copper transporter COPT1 functions in root elongation and pollen development. J Biol Chem (2004) 1.35
Regulation of the Saccharomyces cerevisiae Slt2 kinase pathway by the stress-inducible Sdp1 dual specificity phosphatase. J Biol Chem (2002) 1.31
Structure of the Ctr1 copper trans'PORE'ter reveals novel architecture. Trends Biochem Sci (2006) 1.28
Distinct mechanisms for Ctr1-mediated copper and cisplatin transport. J Biol Chem (2007) 1.27
Charting the travels of copper in eukaryotes from yeast to mammals. Biochim Biophys Acta (2012) 1.25
A stress regulatory network for co-ordinated activation of proteasome expression mediated by yeast heat shock transcription factor. Mol Microbiol (2006) 1.24
A novel role for copper in Ras/mitogen-activated protein kinase signaling. Mol Cell Biol (2012) 1.24
Copper transport into the secretory pathway is regulated by oxygen in macrophages. J Cell Sci (2009) 1.24
Ctr1 is an apical copper transporter in mammalian intestinal epithelial cells in vivo that is controlled at the level of protein stability. J Biol Chem (2010) 1.19
A copper-regulated transporter required for copper acquisition, pigmentation, and specific stages of development in Drosophila melanogaster. J Biol Chem (2003) 1.17
Copper transport activity of yeast Ctr1 is down-regulated via its C terminus in response to excess copper. J Biol Chem (2008) 1.12
Identification of a vacuole-associated metalloreductase and its role in Ctr2-mediated intracellular copper mobilization. J Biol Chem (2007) 1.12
From aging to virulence: forging connections through the study of copper homeostasis in eukaryotic microorganisms. Curr Opin Microbiol (2004) 1.12
De novo appearance and "strain" formation of yeast prion [PSI+] are regulated by the heat-shock transcription factor. Genetics (2006) 1.11
The copper regulon of the human fungal pathogen Cryptococcus neoformans H99. Mol Microbiol (2011) 1.08
The Cth2 ARE-binding protein recruits the Dhh1 helicase to promote the decay of succinate dehydrogenase SDH4 mRNA in response to iron deficiency. J Biol Chem (2008) 1.06
Drosophila Ctr1A functions as a copper transporter essential for development. J Biol Chem (2007) 1.04
Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay. PLoS Genet (2007) 1.04
Host iron withholding demands siderophore utilization for Candida glabrata to survive macrophage killing. PLoS Pathog (2011) 1.03
Higher plants possess two different types of ATX1-like copper chaperones. Biochem Biophys Res Commun (2007) 1.03
Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2α. Cell Metab (2013) 1.02
The Smk1p MAP kinase negatively regulates Gsc2p, a 1,3-beta-glucan synthase, during spore wall morphogenesis in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2005) 1.02
Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis. Am J Physiol Gastrointest Liver Physiol (2008) 1.01
Altered microglial copper homeostasis in a mouse model of Alzheimer's disease. J Neurochem (2010) 1.01
Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1. Pharmacogenetics (2003) 1.01
Model peptides provide new insights into the role of histidine residues as potential ligands in human cellular copper acquisition via Ctr1. J Am Chem Soc (2011) 1.01
Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. PLoS One (2011) 0.98
Expressional control of a cadmium-transporting P1B-type ATPase by a metal sensing degradation signal. J Biol Chem (2008) 0.96
Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain. Proc Natl Acad Sci U S A (2013) 0.96
The Cdk-activating kinase Cak1p promotes meiotic S phase through Ime2p. Mol Cell Biol (2003) 0.95
Negative feedback regulation of the yeast CTH1 and CTH2 mRNA binding proteins is required for adaptation to iron deficiency and iron supplementation. Mol Cell Biol (2013) 0.95
The ABCDs of periplasmic copper trafficking. Structure (2002) 0.93
How copper traverses cellular membranes through the mammalian copper transporter 1, Ctr1. Ann N Y Acad Sci (2014) 0.93
Copper at the front line of the host-pathogen battle. PLoS Pathog (2012) 0.92
Bud morphogenesis and the actin and microtubule cytoskeletons during budding in the corn smut fungus, Ustilago maydis. Fungal Genet Biol (2002) 0.91
A cadmium-transporting P1B-type ATPase in yeast Saccharomyces cerevisiae. J Biol Chem (2006) 0.91
Post-transcriptional regulation of gene expression in response to iron deficiency: co-ordinated metabolic reprogramming by yeast mRNA-binding proteins. Biochem Soc Trans (2008) 0.91
Cadmium-mediated rescue from ER-associated degradation induces expression of its exporter. Proc Natl Acad Sci U S A (2009) 0.90
Early recruitment of AU-rich element-containing mRNAs determines their cytosolic fate during iron deficiency. Mol Cell Biol (2010) 0.89
PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2). Pharmacol Rev (2003) 0.89
Transcriptional activation in yeast in response to copper deficiency involves copper-zinc superoxide dismutase. J Biol Chem (2008) 0.89
Genome-wide identification of the regulatory targets of a transcription factor using biochemical characterization and computational genomic analysis. BMC Bioinformatics (2005) 0.89
Cell polarity protein Spa2P associates with proteins involved in actin function in Saccharomyces cerevisiae. Mol Biol Cell (2005) 0.88
Dissection of the relative contribution of the Schizosaccharomyces pombe Ctr4 and Ctr5 proteins to the copper transport and cell surface delivery functions. Microbiology (2011) 0.88
Cti6 is an Rpd3-Sin3 histone deacetylase-associated protein required for growth under iron-limiting conditions in Saccharomyces cerevisiae. J Biol Chem (2004) 0.88
High affinity copper transport protein in the lizard Podarcis sicula: molecular cloning, functional characterization and expression in somatic tissues, follicular oocytes and eggs. Biochim Biophys Acta (2002) 0.87
Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load. PLoS One (2012) 0.86
SLC31 (CTR) family of copper transporters in health and disease. Mol Aspects Med (2013) 0.86
Enhancer of decapping proteins 1 and 2 are important for translation during heat stress in Saccharomyces cerevisiae. Mol Microbiol (2009) 0.85
Deciphering human heat shock transcription factor 1 regulation via post-translational modification in yeast. PLoS One (2011) 0.84
The Drosophila copper transporter Ctr1C functions in male fertility. J Biol Chem (2010) 0.83
Introduction to Human Disorders of Copper Metabolism. Ann N Y Acad Sci (2014) 0.82
Full characterization of the Cu-, Zn-, and Cd-binding properties of CnMT1 and CnMT2, two metallothioneins of the pathogenic fungus Cryptococcus neoformans acting as virulence factors. Metallomics (2014) 0.82
Yeast protective response to arsenate involves the repression of the high affinity iron uptake system. Biochim Biophys Acta (2013) 0.80
PharmGKB update: III. Genetic variants of SLC22A1, solute carrier family 22 (organic cation transporter), member 1. Pharmacol Rev (2004) 0.78
Genetic selection for constitutively trimerized human HSF1 mutants identifies a role for coiled-coil motifs in DNA binding. G3 (Bethesda) (2013) 0.78
YCF1-mediated cadmium resistance in yeast is dependent on copper metabolism and antioxidant enzymes. Antioxid Redox Signal (2014) 0.78